{"id":2059,"date":"2020-12-14T14:19:00","date_gmt":"2020-12-14T14:19:00","guid":{"rendered":"https:\/\/www.joinaresearchstudy.com\/?p=2059"},"modified":"2020-12-14T14:19:01","modified_gmt":"2020-12-14T14:19:01","slug":"erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment","status":"publish","type":"post","link":"https:\/\/joinaresearchstudy.com\/es\/2020\/12\/14\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\/","title":{"rendered":"Los sitios de ensayos cl\u00ednicos de ERG contribuyen a la aprobaci\u00f3n del tratamiento de Regeneron contra la COVID-19"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Ante el alarmante aumento de casos de COVID-19 en Estados Unidos, la Autorizaci\u00f3n de Uso de Emergencia del tratamiento de Regeneron contra la COVID-19 lleg\u00f3 en el momento justo. La FDA anunci\u00f3 a finales del mes pasado que casirivimab e imdevimab, dos anticuerpos monoclonales, recibieron la autorizaci\u00f3n de uso de emergencia en pacientes con enfermedad por coronavirus 2019 leve y moderada.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Los ensayos cl\u00ednicos demostraron que los dos medicamentos, cuando se administran juntos, redujeron significativamente las cargas virales, as\u00ed como las hospitalizaciones y las visitas a salas de emergencia relacionadas con COVID-19 en pacientes con alto riesgo de progresi\u00f3n de la enfermedad.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Bill Martin, doctor del Evolution Research Group (ERG), que gestiona centros de investigaci\u00f3n cl\u00ednica y presta servicios de desarrollo de f\u00e1rmacos, se\u00f1al\u00f3: \u00abNuestro equipo est\u00e1 agradecido de haber participado en un programa tan importante. Agradecemos a los numerosos voluntarios de nuestros centros de investigaci\u00f3n que han contribuido al desarrollo de este importante nuevo tratamiento\u00bb.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">El Director M\u00e9dico de ERG declar\u00f3: \u00abEstamos encantados con la reciente decisi\u00f3n de la FDA de permitir el uso de emergencia, lo cual tendr\u00e1 un gran impacto en los pacientes, sus familias y el personal sanitario en medio de la pandemia. Estos resultados son el resultado de investigaciones pioneras y del enorme esfuerzo de innumerables investigadores\u00bb.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Casirivimab e imdevimab fueron dise\u00f1ados para actuar inhibiendo espec\u00edficamente la infectividad del SARS-CoV-2, el virus que causa la COVID-19. Ambos f\u00e1rmacos se administran conjuntamente mediante infusi\u00f3n y no est\u00e1n indicados para personas con s\u00edntomas graves ni hospitalizadas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Los funcionarios de la FDA tambi\u00e9n afirmaron que el uso de emergencia puede aliviar la carga del sistema de salud y mantener a los pacientes fuera del hospital.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">ERG y sus sitios de investigaci\u00f3n cl\u00ednica est\u00e1n dedicados a promover la medicina y contin\u00faan trabajando con compa\u00f1\u00edas biofarmac\u00e9uticas en el desarrollo de nuevos tratamientos y vacunas para COVID-19.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Para obtener m\u00e1s informaci\u00f3n sobre la autorizaci\u00f3n de uso de emergencia de Regeneron, visite <a href=\"https:\/\/www.regeneron.com\/casirivimab-imdevimab\">regeneron.com<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibodies-treatment-covid-19\">https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibodies-treatment-covid-19<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/investor.regeneron.com\/news-releases\/news-release-details\/regenerons-covid-19-outpatient-trial-prospectively-demonstrates\">https:\/\/investor.regeneron.com\/news-releases\/news-release-details\/regenerons-covid-19-outpatient-trial-prospectively-demonstrates<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Ante el alarmante aumento de casos de COVID-19 en Estados Unidos, la autorizaci\u00f3n de uso de emergencia del tratamiento de Regeneron contra la COVID-19 era crucial. La FDA anunci\u00f3 a finales del mes pasado que casirivimab e imdevimab, dos anticuerpos monoclonales, recibieron autorizaci\u00f3n de uso de emergencia en pacientes con enfermedad por coronavirus 2019 leve y moderada. Los ensayos cl\u00ednicos demostraron que ambos\u2026 <\/p>\n<p class=\"read-more-container\"><a title=\"Los sitios de ensayos cl\u00ednicos de ERG contribuyen a la aprobaci\u00f3n del tratamiento de Regeneron contra la COVID-19\" class=\"read-more button\" href=\"https:\/\/joinaresearchstudy.com\/es\/2020\/12\/14\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\/#more-2059\" aria-label=\"Leer m\u00e1s sobre Los sitios de ensayos cl\u00ednicos de ERG contribuyen a la aprobaci\u00f3n del tratamiento COVID-19 de Regeneron\">Leer m\u00e1s<\/a><\/p>","protected":false},"author":1,"featured_media":2062,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[77,10,76],"class_list":["post-2059","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","tag-covid-treatment","tag-covid-19","tag-regeneron","infinite-scroll-item","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-50"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ERG Clinical Trial Sites Contribute to Approval of Regeneron\u2019s COVID-19 Treatment - Evolution Research Group<\/title>\n<meta name=\"description\" content=\"Evolution Research Group Clinical Trial Sites Contribute to FDA Approval of Regeneron\u2019s COVID-19 Treatment.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/joinaresearchstudy.com\/es\/2020\/12\/14\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ERG Clinical Trial Sites Contribute to Approval of Regeneron\u2019s COVID-19 Treatment - Evolution Research Group\" \/>\n<meta property=\"og:description\" content=\"Evolution Research Group Clinical Trial Sites Contribute to FDA Approval of Regeneron\u2019s COVID-19 Treatment.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/joinaresearchstudy.com\/es\/2020\/12\/14\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\/\" \/>\n<meta property=\"og:site_name\" content=\"Evolution Research Group\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-14T14:19:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-12-14T14:19:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/joinaresearchstudy.com\/wp-content\/uploads\/2020\/12\/ERG_Facebook_Blog-COVID_09DEC2020_JS.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Imagebloom\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Imagebloom\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/joinaresearchstudy.com\\\/2020\\\/12\\\/14\\\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/joinaresearchstudy.com\\\/2020\\\/12\\\/14\\\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\\\/\"},\"author\":{\"name\":\"Imagebloom\",\"@id\":\"https:\\\/\\\/joinaresearchstudy.com\\\/#\\\/schema\\\/person\\\/5487be866dea1466c37d446eaad24331\"},\"headline\":\"ERG Clinical Trial Sites Contribute to Approval of Regeneron\u2019s COVID-19 Treatment\",\"datePublished\":\"2020-12-14T14:19:00+00:00\",\"dateModified\":\"2020-12-14T14:19:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/joinaresearchstudy.com\\\/2020\\\/12\\\/14\\\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\\\/\"},\"wordCount\":323,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/joinaresearchstudy.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/joinaresearchstudy.com\\\/2020\\\/12\\\/14\\\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/joinaresearchstudy.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/ERG_Facebook_Blog-COVID_09DEC2020_JS.jpg\",\"keywords\":[\"COVID TREATMENT\",\"COVID-19\",\"REGENERON\"],\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/joinaresearchstudy.com\\\/2020\\\/12\\\/14\\\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\\\/\",\"url\":\"https:\\\/\\\/joinaresearchstudy.com\\\/2020\\\/12\\\/14\\\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\\\/\",\"name\":\"ERG Clinical Trial Sites Contribute to Approval of Regeneron\u2019s COVID-19 Treatment - Evolution Research Group\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/joinaresearchstudy.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/joinaresearchstudy.com\\\/2020\\\/12\\\/14\\\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/joinaresearchstudy.com\\\/2020\\\/12\\\/14\\\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/joinaresearchstudy.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/ERG_Facebook_Blog-COVID_09DEC2020_JS.jpg\",\"datePublished\":\"2020-12-14T14:19:00+00:00\",\"dateModified\":\"2020-12-14T14:19:01+00:00\",\"description\":\"Evolution Research Group Clinical Trial Sites Contribute to FDA Approval of Regeneron\u2019s COVID-19 Treatment.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/joinaresearchstudy.com\\\/2020\\\/12\\\/14\\\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/joinaresearchstudy.com\\\/2020\\\/12\\\/14\\\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/joinaresearchstudy.com\\\/2020\\\/12\\\/14\\\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\\\/#primaryimage\",\"url\":\"https:\\\/\\\/joinaresearchstudy.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/ERG_Facebook_Blog-COVID_09DEC2020_JS.jpg\",\"contentUrl\":\"https:\\\/\\\/joinaresearchstudy.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/ERG_Facebook_Blog-COVID_09DEC2020_JS.jpg\",\"width\":1200,\"height\":630,\"caption\":\"Regeneron's Monoclonal antibodies for treatment of COVID-19 Coronavirus Approved by FDA\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/joinaresearchstudy.com\\\/2020\\\/12\\\/14\\\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/joinaresearchstudy.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ERG Clinical Trial Sites Contribute to Approval of Regeneron\u2019s COVID-19 Treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/joinaresearchstudy.com\\\/#website\",\"url\":\"https:\\\/\\\/joinaresearchstudy.com\\\/\",\"name\":\"Evolution Research Group\",\"description\":\"Join a Research Study\",\"publisher\":{\"@id\":\"https:\\\/\\\/joinaresearchstudy.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/joinaresearchstudy.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/joinaresearchstudy.com\\\/#organization\",\"name\":\"Evolution Research Group\",\"url\":\"https:\\\/\\\/joinaresearchstudy.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/joinaresearchstudy.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/joinaresearchstudy.com\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/ERG-JARS_LOGO.png\",\"contentUrl\":\"https:\\\/\\\/joinaresearchstudy.com\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/ERG-JARS_LOGO.png\",\"width\":587,\"height\":170,\"caption\":\"Evolution Research Group\"},\"image\":{\"@id\":\"https:\\\/\\\/joinaresearchstudy.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/joinaresearchstudy.com\\\/#\\\/schema\\\/person\\\/5487be866dea1466c37d446eaad24331\",\"name\":\"Imagebloom\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c1143e0c8d8aaf6e97b68245ed35f7cd8cc1fd7a2aeb28dccb6c27b981d5923a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c1143e0c8d8aaf6e97b68245ed35f7cd8cc1fd7a2aeb28dccb6c27b981d5923a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c1143e0c8d8aaf6e97b68245ed35f7cd8cc1fd7a2aeb28dccb6c27b981d5923a?s=96&d=mm&r=g\",\"caption\":\"Imagebloom\"},\"sameAs\":[\"http:\\\/\\\/jars.wpengine.com\"],\"url\":\"https:\\\/\\\/joinaresearchstudy.com\\\/es\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Los centros de ensayos cl\u00ednicos de ERG contribuyen a la aprobaci\u00f3n del tratamiento de Regeneron contra la COVID-19 - Evolution Research Group","description":"Los sitios de ensayos cl\u00ednicos de Evolution Research Group contribuyen a la aprobaci\u00f3n por parte de la FDA del tratamiento de Regeneron contra la COVID-19.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/joinaresearchstudy.com\/es\/2020\/12\/14\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\/","og_locale":"es_MX","og_type":"article","og_title":"ERG Clinical Trial Sites Contribute to Approval of Regeneron\u2019s COVID-19 Treatment - Evolution Research Group","og_description":"Evolution Research Group Clinical Trial Sites Contribute to FDA Approval of Regeneron\u2019s COVID-19 Treatment.","og_url":"https:\/\/joinaresearchstudy.com\/es\/2020\/12\/14\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\/","og_site_name":"Evolution Research Group","article_published_time":"2020-12-14T14:19:00+00:00","article_modified_time":"2020-12-14T14:19:01+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/joinaresearchstudy.com\/wp-content\/uploads\/2020\/12\/ERG_Facebook_Blog-COVID_09DEC2020_JS.jpg","type":"image\/jpeg"}],"author":"Imagebloom","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Imagebloom","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/joinaresearchstudy.com\/2020\/12\/14\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\/#article","isPartOf":{"@id":"https:\/\/joinaresearchstudy.com\/2020\/12\/14\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\/"},"author":{"name":"Imagebloom","@id":"https:\/\/joinaresearchstudy.com\/#\/schema\/person\/5487be866dea1466c37d446eaad24331"},"headline":"ERG Clinical Trial Sites Contribute to Approval of Regeneron\u2019s COVID-19 Treatment","datePublished":"2020-12-14T14:19:00+00:00","dateModified":"2020-12-14T14:19:01+00:00","mainEntityOfPage":{"@id":"https:\/\/joinaresearchstudy.com\/2020\/12\/14\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\/"},"wordCount":323,"commentCount":0,"publisher":{"@id":"https:\/\/joinaresearchstudy.com\/#organization"},"image":{"@id":"https:\/\/joinaresearchstudy.com\/2020\/12\/14\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/joinaresearchstudy.com\/wp-content\/uploads\/2020\/12\/ERG_Facebook_Blog-COVID_09DEC2020_JS.jpg","keywords":["COVID TREATMENT","COVID-19","REGENERON"],"articleSection":["Uncategorized"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/joinaresearchstudy.com\/2020\/12\/14\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\/","url":"https:\/\/joinaresearchstudy.com\/2020\/12\/14\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\/","name":"Los centros de ensayos cl\u00ednicos de ERG contribuyen a la aprobaci\u00f3n del tratamiento de Regeneron contra la COVID-19 - Evolution Research Group","isPartOf":{"@id":"https:\/\/joinaresearchstudy.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/joinaresearchstudy.com\/2020\/12\/14\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\/#primaryimage"},"image":{"@id":"https:\/\/joinaresearchstudy.com\/2020\/12\/14\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/joinaresearchstudy.com\/wp-content\/uploads\/2020\/12\/ERG_Facebook_Blog-COVID_09DEC2020_JS.jpg","datePublished":"2020-12-14T14:19:00+00:00","dateModified":"2020-12-14T14:19:01+00:00","description":"Los sitios de ensayos cl\u00ednicos de Evolution Research Group contribuyen a la aprobaci\u00f3n por parte de la FDA del tratamiento de Regeneron contra la COVID-19.","breadcrumb":{"@id":"https:\/\/joinaresearchstudy.com\/2020\/12\/14\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/joinaresearchstudy.com\/2020\/12\/14\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/joinaresearchstudy.com\/2020\/12\/14\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\/#primaryimage","url":"https:\/\/joinaresearchstudy.com\/wp-content\/uploads\/2020\/12\/ERG_Facebook_Blog-COVID_09DEC2020_JS.jpg","contentUrl":"https:\/\/joinaresearchstudy.com\/wp-content\/uploads\/2020\/12\/ERG_Facebook_Blog-COVID_09DEC2020_JS.jpg","width":1200,"height":630,"caption":"Regeneron's Monoclonal antibodies for treatment of COVID-19 Coronavirus Approved by FDA"},{"@type":"BreadcrumbList","@id":"https:\/\/joinaresearchstudy.com\/2020\/12\/14\/erg-clinical-trial-sites-contribute-to-approval-of-regenerons-covid-19-treatment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/joinaresearchstudy.com\/"},{"@type":"ListItem","position":2,"name":"ERG Clinical Trial Sites Contribute to Approval of Regeneron\u2019s COVID-19 Treatment"}]},{"@type":"WebSite","@id":"https:\/\/joinaresearchstudy.com\/#website","url":"https:\/\/joinaresearchstudy.com\/","name":"Grupo de Investigaci\u00f3n de la Evoluci\u00f3n","description":"\u00danase a un estudio de investigaci\u00f3n","publisher":{"@id":"https:\/\/joinaresearchstudy.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/joinaresearchstudy.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/joinaresearchstudy.com\/#organization","name":"Grupo de Investigaci\u00f3n de la Evoluci\u00f3n","url":"https:\/\/joinaresearchstudy.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/joinaresearchstudy.com\/#\/schema\/logo\/image\/","url":"https:\/\/joinaresearchstudy.com\/wp-content\/uploads\/2020\/05\/ERG-JARS_LOGO.png","contentUrl":"https:\/\/joinaresearchstudy.com\/wp-content\/uploads\/2020\/05\/ERG-JARS_LOGO.png","width":587,"height":170,"caption":"Evolution Research Group"},"image":{"@id":"https:\/\/joinaresearchstudy.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/joinaresearchstudy.com\/#\/schema\/person\/5487be866dea1466c37d446eaad24331","name":"Imagebloom","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/c1143e0c8d8aaf6e97b68245ed35f7cd8cc1fd7a2aeb28dccb6c27b981d5923a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c1143e0c8d8aaf6e97b68245ed35f7cd8cc1fd7a2aeb28dccb6c27b981d5923a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c1143e0c8d8aaf6e97b68245ed35f7cd8cc1fd7a2aeb28dccb6c27b981d5923a?s=96&d=mm&r=g","caption":"Imagebloom"},"sameAs":["http:\/\/jars.wpengine.com"],"url":"https:\/\/joinaresearchstudy.com\/es\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/joinaresearchstudy.com\/es\/wp-json\/wp\/v2\/posts\/2059","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/joinaresearchstudy.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/joinaresearchstudy.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/joinaresearchstudy.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/joinaresearchstudy.com\/es\/wp-json\/wp\/v2\/comments?post=2059"}],"version-history":[{"count":0,"href":"https:\/\/joinaresearchstudy.com\/es\/wp-json\/wp\/v2\/posts\/2059\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/joinaresearchstudy.com\/es\/wp-json\/wp\/v2\/media\/2062"}],"wp:attachment":[{"href":"https:\/\/joinaresearchstudy.com\/es\/wp-json\/wp\/v2\/media?parent=2059"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/joinaresearchstudy.com\/es\/wp-json\/wp\/v2\/categories?post=2059"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/joinaresearchstudy.com\/es\/wp-json\/wp\/v2\/tags?post=2059"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}